🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/02/2016 11,08 11,94 10,96 11,73 +3,90% 8,84% 1.165.000
10/02/2016 12,00 12,00 11,01 11,29 +0,98% 8,25% 1.138.100
09/02/2016 10,64 11,44 10,20 11,18 +4,10% 11,65% 1.226.500
08/02/2016 11,85 11,98 10,60 10,74 -12,11% 11,65% 2.234.400
05/02/2016 12,08 12,28 11,68 12,22 -0,08% 4,97% 1.335.400
04/02/2016 11,95 12,53 11,59 12,23 +1,66% 7,87% 854.100
03/02/2016 12,25 12,48 11,23 12,03 -1,55% 10,20% 1.586.300
02/02/2016 12,19 12,64 12,03 12,22 -1,29% 5,00% 1.205.300
01/02/2016 11,68 12,62 11,46 12,38 +4,21% 9,93% 1.619.000
29/01/2016 11,24 11,96 11,10 11,88 +5,13% 7,65% 1.480.400
28/01/2016 11,99 12,31 11,23 11,30 -5,28% 9,01% 1.206.800
27/01/2016 12,10 12,34 11,74 11,93 -1,89% 4,96% 1.387.600
26/01/2016 12,48 12,55 11,75 12,16 +0,66% 6,41% 1.794.100
25/01/2016 12,03 12,95 11,81 12,08 -0,25% 9,48% 1.807.500
22/01/2016 12,67 12,89 12,01 12,11 +1,17% 6,95% 2.668.300
21/01/2016 13,49 13,49 11,70 11,97 -9,73% 13,27% 3.011.900
20/01/2016 13,00 13,50 12,05 13,26 -1,34% 11,15% 3.033.900
19/01/2016 14,39 14,75 12,50 13,44 -5,88% 15,64% 5.459.800
15/01/2016 15,00 15,78 12,80 14,28 -54,85% 19,87% 17.601.700
14/01/2016 32,28 33,50 29,05 31,63 -1,22% 13,79% 3.701.600
13/01/2016 34,23 34,32 31,38 32,02 -5,80% 8,59% 1.346.300
12/01/2016 34,92 35,83 32,61 33,99 -1,22% 9,22% 1.382.300
11/01/2016 36,12 36,24 33,36 34,41 -4,23% 7,97% 1.421.600
08/01/2016 36,57 37,17 35,70 35,93 -0,77% 4,02% 944.800
07/01/2016 35,98 37,48 35,35 36,21 -1,39% 5,92% 958.000
06/01/2016 37,10 37,80 36,30 36,72 -2,34% 4,04% 1.095.300
05/01/2016 38,20 38,63 37,41 37,60 -1,23% 3,19% 581.200
04/01/2016 37,85 38,80 37,33 38,07 -1,32% 3,88% 882.400
31/12/2015 38,55 39,86 38,26 38,58 -0,23% 4,15% 780.400
30/12/2015 39,50 41,00 38,54 38,67 -1,15% 6,23% 1.254.800